FTC plans to sue PBMs over high cost of insulin, other medicines

The agency is focusing on the controversial role of rebates that are paid by drugmakers to PBMs to win favorable placement on formularies.

July 10, 2024 Check out STAT+

Sponsored By

Adobe STAT+ | FTC plans to sue PBMs over the high cost of insulin and other medicines The agency is focusing on the controversial role of rebates that are paid by drugmakers to PBMs to win favorable placement on formularies. By Ed Silverman STAT+ | Biopharma layoffs are leaving the industry's scientists reeling — and in search of scarce opportunities About 67% of life science employees laid off during the first half of 2024 were at companies with more than $1 billion in annual sales, according to BIO. By Jonathan Wosen Free medical school tuition unlikely to have a major impact on the U.S. health care system Donors made medical school tuition free at Johns Hopkins, Albert Einstein College of Medicine. Experts weigh in on implications, long-term impact. By Annalisa Merelli Chip Somodevilla/Getty Images Opinion: Listen: Anthony Fauci on presidents, bird flu, and turning down a multimillion-dollar job Dr. Anthony Fauci sits down with STAT to discuss politics, bird flu, turning down a million-dollar job — and keeping a secret while having dinner with Bono. By Rick Berke and Helen Branswell STAT+ | Sanford Health aims to shake off a run of failed deals by snapping up a $3 billion Wisconsin health system The deal between Sanford Health and Marshfield Clinic would create a giant rural health system with 56 hospitals and 56,000 workers. By Tara Bannow STAT+ | Biden administration ignores calls to bolster hospital price transparency The U.S. passed on a opportunity to strengthen regulations that dictate how hospitals publish their prices, ignoring pleas from patient advocates. By Bob Herman Adobe Researchers identify 'molecular switch' in lupus that could stymie harmful immune response Harvard researchers say the discovery shows a path toward righting the balance between helpful and damage-promoting immune cells in lupus. By Isabella Cueto STAT+ | VC Flagship Pioneering raises $3.6 billion in new funds The VC firm said it plans to use the funding to develop around 25 new companies focused on human health, sustainability, and artificial intelligence, By Allison DeAngelis

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser